2021
Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders
Meyer J, Price C, Tracey D, Sharpless L, Song Y, Madden L, Elwyn G, Altice F. Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders. Patient Preference And Adherence 2021, 15: 1913-1927. PMID: 34511887, PMCID: PMC8420782, DOI: 10.2147/ppa.s315543.Peer-Reviewed Original ResearchSubstance use disordersPersonal HIV riskHIV preventionAddiction treatment servicesHIV riskUse disordersTreatment servicesPatient-centered decision aidAwareness of PrEPHIV prevention cascadeInitiation of PrEPPre-exposure prophylaxisOpioid use disorderStandard of careDecision aidAlcohol use severityHalf of participantsAddiction treatment programsDA participantsPrevention cascadePrimary outcomeIndependent correlatesHigh riskDecisional preferencesHigher alcohol use severityThe opioid crisis and HIV in the USA: deadly synergies
Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice FL, Ortenzio L, Beyrer C. The opioid crisis and HIV in the USA: deadly synergies. The Lancet 2021, 397: 1139-1150. PMID: 33617769, DOI: 10.1016/s0140-6736(21)00391-3.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnalgesics, OpioidBlack or African AmericanCase-Control StudiesDisease OutbreaksEvidence-Based MedicineFemaleFentanylHealth Services AccessibilityHispanic or LatinoHIV InfectionsHumansMaleNeedle SharingOpiate OverdoseOpioid EpidemicOpioid-Related DisordersSocial StigmaUnited StatesWhite PeopleYoung AdultConceptsNew HIV diagnosesHIV diagnosisOpioid epidemicHIV preventionMultiple evidence-based interventionsGreat public health problemRecent HIV outbreaksOpioid overdose death ratesOpioid use disorderLarge central metropolitan areasPublic health problemOverdose death ratesComprehensive health careEvidence-based interventionsDeadly synergyHIV acquisitionSynthetic opioid fentanylSyringe sharingHIV outbreakUse disordersOpioid fentanylTreatment servicesHealth problemsOpioid crisisDeath rate
2017
Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine
Madden L, Bojko MJ, Farnum S, Mazhnaya A, Fomenko T, Marcus R, Barry D, Ivanchuk I, Kolomiets V, Filippovych S, Dvoryak S, Altice FL. Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine. International Journal Of Drug Policy 2017, 49: 48-53. PMID: 28957756, DOI: 10.1016/j.drugpo.2017.07.025.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyNominal group techniqueAgonist therapyBuprenorphine maintenance treatmentAddiction treatment approachesImplementation science strategiesOAT servicesMaintenance treatmentClinical providersTreatment approachesTreatment servicesNGT discussionRegional controlTherapyCliniciansGroup techniqueStructural barriersAssessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia
Khan F, Krishnan A, Ghani MA, Wickersham JA, Fu JJ, Lim SH, Dhaliwal SK, Kamarulzaman A, Altice FL. Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia. Substance Use & Misuse 2017, 53: 249-259. PMID: 28635521, PMCID: PMC5664175, DOI: 10.1080/10826084.2016.1267217.Peer-Reviewed Original ResearchConceptsCompulsory drug detention centersDrug useTreatment servicesVoluntary drug treatment centresTreatment programMethadone maintenance therapyEarly treatment outcomesCross-sectional convenience surveyDrug treatment centersSubstance abuse treatment programsDrug treatment programsAddiction treatment servicesSevere mental health issuesPast drug useMental health issuesNational Anti-Drug AgencyMaintenance therapyCare centerClient satisfactionTreatment outcomesTreatment centersDrug use levelsHealth servicesInvoluntary detentionSelf-reported satisfaction
2013
A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment
Vagenas P, Azbel L, Polonsky M, Kerimi N, Mamyrov M, Dvoryak S, Altice FL. A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment. Drug And Alcohol Dependence 2013, 132: s25-s31. PMID: 23932844, PMCID: PMC3825758, DOI: 10.1016/j.drugalcdep.2013.07.010.Peer-Reviewed Original ResearchConceptsOpioid substitution therapyDrug-related health problemsHIV preventionHealth problemsHIV sentinel surveillanceHIV prevention interventionsConcentration of HIVHIV incidenceHIV casesSubstitution therapyHIV prevalenceSentinel surveillancePrevention interventionsRisk populationsDisease RegistryTreatment servicesHealth reportingSubstance useHealthcare servicesRecent dataPrevalenceCrucial interventionPreventionInterventionOnline databases
2011
Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative
Weiss L, Netherland J, Egan JE, Flanigan TP, Fiellin DA, Finkelstein R, Altice FL. Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 56: s68-s75. PMID: 21317597, DOI: 10.1097/qai.0b013e31820a8226.Peer-Reviewed Original ResearchMeSH KeywordsAmbulatory CareAnti-HIV AgentsBuprenorphineBuprenorphine, Naloxone Drug CombinationDelivery of Health Care, IntegratedHealth ResourcesHealth Services Needs and DemandHIV InfectionsHumansNaloxoneNarcotic AntagonistsOpiate Substitution TreatmentOpioid-Related DisordersPrimary Health CareSubstance Abuse Treatment CentersUnited StatesConceptsBUP/NXHIV clinical careBup/HIV evaluationClinical careBuprenorphine/naloxone treatmentGeneral internal medicine physiciansHospital-based clinicsInternal medicine physiciansSite principal investigatorsExperiences of physiciansMental health issuesPrincipal investigatorHIV providersMultisubstance useNX treatmentHIV careIntegrated HIVNaloxone treatmentUrine toxicologyMultiple prescribersHIV treatmentMedicine physiciansTreatment servicesProvider experience
1995
Women Living with Drug Abuse and HIV Disease: Drug Abuse Treatment Access and Secondary Prevention Issues
Weissman G, Melchior L, Huba G, Smereck G, Needle R, McCarthy S, Jones A, Genser S, Cottler L, Booth R, Altice F. Women Living with Drug Abuse and HIV Disease: Drug Abuse Treatment Access and Secondary Prevention Issues. Journal Of Psychoactive Drugs 1995, 27: 401-411. PMID: 8788695, DOI: 10.1080/02791072.1995.10471704.Peer-Reviewed Original ResearchConceptsHIV secondary preventionDrug abuse treatment servicesDrug abuse treatmentSecondary preventionTreatment servicesAbuse treatmentDrug abuseOutpatient drug-free treatmentSecondary prevention issuesDrug-free treatmentDrug abuse treatment systemFirst yearHIV diseaseInjection drugsService utilizationTreatment accessDrug abusersDrug usersTreatment availabilityPositive findingsOutpatient drug abuse treatmentHealth resourcesDrug detoxificationWomenPrevention issues